Association of CTLA4 Gene Polymorphism with Transfusion Reaction after Infusion of Leukoreduced Blood Component

Leukocytes and cytokines in blood units have been known to be involved in febrile non-hemolytic transfusion reaction (FNHTR), and these adverse reactions still occur while using pre-storage leukoreduced blood products. Blood transfusion is similar to transplantation because both implant allogeneic c...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical medicine Vol. 8; no. 11; p. 1961
Main Authors Wen, Ying-Hao, Lin, Wei-Tzu, Wang, Wei-Ting, Chiueh, Tzong-Shi, Chen, Ding-Ping
Format Journal Article
LanguageEnglish
Published Switzerland MDPI 13.11.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Leukocytes and cytokines in blood units have been known to be involved in febrile non-hemolytic transfusion reaction (FNHTR), and these adverse reactions still occur while using pre-storage leukoreduced blood products. Blood transfusion is similar to transplantation because both implant allogeneic cells or organs into the recipient. CTLA4 gene polymorphism was found to be associated with graft-versus-host disease in hematopoietic stem cell transplantation. We performed a prospective cohort study at a major tertiary care center to investigate the correlation of CTLA4 gene polymorphism and transfusion reactions. Selected CTLA4 gene SNPs were genotyped and compared between patients with transfusion-associated adverse reactions (TAARs) and healthy controls. Nineteen patients and 20 healthy subjects were enrolled. There were 4 SNPs showing differences in allele frequency between patients and controls, and the frequency of “A” allele of rs4553808, “G” allele of rs62182595, “G” allele of rs16840252, and “C” allele of rs5742909 were significantly higher in patients than in controls. Moreover, these alleles also showed significantly higher risk of TAARs (OR = 2.357, 95%CI: 1.584–3.508, p = 0.02; OR = 2.357, 95%CI: 1.584–3.508, p = 0.02; OR = 2.462, 95%CI: 1.619–3.742, p = 0.008; OR = 2.357, 95%CI: 1.584–3.508, p = 0.02; OR = 2.357, 95%CI: 1.584–3.508, p = 0.02, respectively). The present study demonstrated the correlation of CTLA4 gene polymorphism and transfusion reaction, and alleles of 4 CTLA4 SNPs with an increased risk of TAARs were found. It is important to explore the potential immune regulatory mechanism affected by SNPs of costimulatory molecules, and it could predict transfusion reaction occurrence and guide preventive actions.
AbstractList Leukocytes and cytokines in blood units have been known to be involved in febrile non-hemolytic transfusion reaction (FNHTR), and these adverse reactions still occur while using pre-storage leukoreduced blood products. Blood transfusion is similar to transplantation because both implant allogeneic cells or organs into the recipient. CTLA4 gene polymorphism was found to be associated with graft-versus-host disease in hematopoietic stem cell transplantation. We performed a prospective cohort study at a major tertiary care center to investigate the correlation of CTLA4 gene polymorphism and transfusion reactions. Selected CTLA4 gene SNPs were genotyped and compared between patients with transfusion-associated adverse reactions (TAARs) and healthy controls. Nineteen patients and 20 healthy subjects were enrolled. There were 4 SNPs showing differences in allele frequency between patients and controls, and the frequency of “A” allele of rs4553808, “G” allele of rs62182595, “G” allele of rs16840252, and “C” allele of rs5742909 were significantly higher in patients than in controls. Moreover, these alleles also showed significantly higher risk of TAARs (OR = 2.357, 95%CI: 1.584–3.508, p = 0.02; OR = 2.357, 95%CI: 1.584–3.508, p = 0.02; OR = 2.462, 95%CI: 1.619–3.742, p = 0.008; OR = 2.357, 95%CI: 1.584–3.508, p = 0.02; OR = 2.357, 95%CI: 1.584–3.508, p = 0.02, respectively). The present study demonstrated the correlation of CTLA4 gene polymorphism and transfusion reaction, and alleles of 4 CTLA4 SNPs with an increased risk of TAARs were found. It is important to explore the potential immune regulatory mechanism affected by SNPs of costimulatory molecules, and it could predict transfusion reaction occurrence and guide preventive actions.
Leukocytes and cytokines in blood units have been known to be involved in febrile non-hemolytic transfusion reaction (FNHTR), and these adverse reactions still occur while using pre-storage leukoreduced blood products. Blood transfusion is similar to transplantation because both implant allogeneic cells or organs into the recipient. CTLA4 gene polymorphism was found to be associated with graft-versus-host disease in hematopoietic stem cell transplantation. We performed a prospective cohort study at a major tertiary care center to investigate the correlation of CTLA4 gene polymorphism and transfusion reactions. Selected CTLA4 gene SNPs were genotyped and compared between patients with transfusion-associated adverse reactions (TAARs) and healthy controls. Nineteen patients and 20 healthy subjects were enrolled. There were 4 SNPs showing differences in allele frequency between patients and controls, and the frequency of "A" allele of rs4553808, "G" allele of rs62182595, "G" allele of rs16840252, and "C" allele of rs5742909 were significantly higher in patients than in controls. Moreover, these alleles also showed significantly higher risk of TAARs (OR = 2.357, 95%CI: 1.584-3.508, p = 0.02; OR = 2.357, 95%CI: 1.584-3.508, p = 0.02; OR = 2.462, 95%CI: 1.619-3.742, p = 0.008; OR = 2.357, 95%CI: 1.584-3.508, p = 0.02; OR = 2.357, 95%CI: 1.584-3.508, p = 0.02, respectively). The present study demonstrated the correlation of CTLA4 gene polymorphism and transfusion reaction, and alleles of 4 CTLA4 SNPs with an increased risk of TAARs were found. It is important to explore the potential immune regulatory mechanism affected by SNPs of costimulatory molecules, and it could predict transfusion reaction occurrence and guide preventive actions.Leukocytes and cytokines in blood units have been known to be involved in febrile non-hemolytic transfusion reaction (FNHTR), and these adverse reactions still occur while using pre-storage leukoreduced blood products. Blood transfusion is similar to transplantation because both implant allogeneic cells or organs into the recipient. CTLA4 gene polymorphism was found to be associated with graft-versus-host disease in hematopoietic stem cell transplantation. We performed a prospective cohort study at a major tertiary care center to investigate the correlation of CTLA4 gene polymorphism and transfusion reactions. Selected CTLA4 gene SNPs were genotyped and compared between patients with transfusion-associated adverse reactions (TAARs) and healthy controls. Nineteen patients and 20 healthy subjects were enrolled. There were 4 SNPs showing differences in allele frequency between patients and controls, and the frequency of "A" allele of rs4553808, "G" allele of rs62182595, "G" allele of rs16840252, and "C" allele of rs5742909 were significantly higher in patients than in controls. Moreover, these alleles also showed significantly higher risk of TAARs (OR = 2.357, 95%CI: 1.584-3.508, p = 0.02; OR = 2.357, 95%CI: 1.584-3.508, p = 0.02; OR = 2.462, 95%CI: 1.619-3.742, p = 0.008; OR = 2.357, 95%CI: 1.584-3.508, p = 0.02; OR = 2.357, 95%CI: 1.584-3.508, p = 0.02, respectively). The present study demonstrated the correlation of CTLA4 gene polymorphism and transfusion reaction, and alleles of 4 CTLA4 SNPs with an increased risk of TAARs were found. It is important to explore the potential immune regulatory mechanism affected by SNPs of costimulatory molecules, and it could predict transfusion reaction occurrence and guide preventive actions.
Leukocytes and cytokines in blood units have been known to be involved in febrile non-hemolytic transfusion reaction (FNHTR), and these adverse reactions still occur while using pre-storage leukoreduced blood products. Blood transfusion is similar to transplantation because both implant allogeneic cells or organs into the recipient. CTLA4 gene polymorphism was found to be associated with graft-versus-host disease in hematopoietic stem cell transplantation. We performed a prospective cohort study at a major tertiary care center to investigate the correlation of CTLA4 gene polymorphism and transfusion reactions. Selected CTLA4 gene SNPs were genotyped and compared between patients with transfusion-associated adverse reactions (TAARs) and healthy controls. Nineteen patients and 20 healthy subjects were enrolled. There were 4 SNPs showing differences in allele frequency between patients and controls, and the frequency of “A” allele of rs4553808, “G” allele of rs62182595, “G” allele of rs16840252, and “C” allele of rs5742909 were significantly higher in patients than in controls. Moreover, these alleles also showed significantly higher risk of TAARs (OR = 2.357, 95%CI: 1.584–3.508, p = 0.02; OR = 2.357, 95%CI: 1.584–3.508, p = 0.02; OR = 2.462, 95%CI: 1.619–3.742, p = 0.008; OR = 2.357, 95%CI: 1.584–3.508, p = 0.02; OR = 2.357, 95%CI: 1.584–3.508, p = 0.02, respectively). The present study demonstrated the correlation of CTLA4 gene polymorphism and transfusion reaction, and alleles of 4 CTLA4 SNPs with an increased risk of TAARs were found. It is important to explore the potential immune regulatory mechanism affected by SNPs of costimulatory molecules, and it could predict transfusion reaction occurrence and guide preventive actions.
Leukocytes and cytokines in blood units have been known to be involved in febrile non-hemolytic transfusion reaction (FNHTR), and these adverse reactions still occur while using pre-storage leukoreduced blood products. Blood transfusion is similar to transplantation because both implant allogeneic cells or organs into the recipient. CTLA4 gene polymorphism was found to be associated with graft-versus-host disease in hematopoietic stem cell transplantation. We performed a prospective cohort study at a major tertiary care center to investigate the correlation of CTLA4 gene polymorphism and transfusion reactions. Selected CTLA4 gene SNPs were genotyped and compared between patients with transfusion-associated adverse reactions (TAARs) and healthy controls. Nineteen patients and 20 healthy subjects were enrolled. There were 4 SNPs showing differences in allele frequency between patients and controls, and the frequency of "A" allele of rs4553808, "G" allele of rs62182595, "G" allele of rs16840252, and "C" allele of rs5742909 were significantly higher in patients than in controls. Moreover, these alleles also showed significantly higher risk of TAARs (OR = 2.357, 95%CI: 1.584-3.508, = 0.02; OR = 2.357, 95%CI: 1.584-3.508, = 0.02; OR = 2.462, 95%CI: 1.619-3.742, = 0.008; OR = 2.357, 95%CI: 1.584-3.508, = 0.02; OR = 2.357, 95%CI: 1.584-3.508, = 0.02, respectively). The present study demonstrated the correlation of CTLA4 gene polymorphism and transfusion reaction, and alleles of 4 CTLA4 SNPs with an increased risk of TAARs were found. It is important to explore the potential immune regulatory mechanism affected by SNPs of costimulatory molecules, and it could predict transfusion reaction occurrence and guide preventive actions.
Author Wang, Wei-Ting
Wen, Ying-Hao
Chiueh, Tzong-Shi
Chen, Ding-Ping
Lin, Wei-Tzu
AuthorAffiliation 2 Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan
1 Department of Laboratory Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan; b9209011@cgmh.org.tw (Y.-H.W.); berry0908@cgmh.org.tw (W.-T.L.); s1223@adm.cgmh.org.tw (W.-T.W.); drche0523@cloud.cgmh.org.tw (T.-S.C.)
4 Department of Medical Biotechnology and Laboratory Science, Chang Gung University, Taoyuan 33302, Taiwan
3 Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan
AuthorAffiliation_xml – name: 1 Department of Laboratory Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan; b9209011@cgmh.org.tw (Y.-H.W.); berry0908@cgmh.org.tw (W.-T.L.); s1223@adm.cgmh.org.tw (W.-T.W.); drche0523@cloud.cgmh.org.tw (T.-S.C.)
– name: 2 Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan
– name: 3 Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan
– name: 4 Department of Medical Biotechnology and Laboratory Science, Chang Gung University, Taoyuan 33302, Taiwan
Author_xml – sequence: 1
  givenname: Ying-Hao
  surname: Wen
  fullname: Wen, Ying-Hao
– sequence: 2
  givenname: Wei-Tzu
  surname: Lin
  fullname: Lin, Wei-Tzu
– sequence: 3
  givenname: Wei-Ting
  surname: Wang
  fullname: Wang, Wei-Ting
– sequence: 4
  givenname: Tzong-Shi
  surname: Chiueh
  fullname: Chiueh, Tzong-Shi
– sequence: 5
  givenname: Ding-Ping
  surname: Chen
  fullname: Chen, Ding-Ping
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31766247$$D View this record in MEDLINE/PubMed
BookMark eNptkV1PHCEYhUljU6160x_QcGlMtvIxM8CNybpRa7JJjdleE5Z56WJnYIUZjf9e1LVaIzcQOOc55Lxf0VaIARD6RskPzhU5ura9pJSqhn5CO4wIMSFc8q035220n_M1KUvKilHxBW1zKpqGVWIHxWnO0Xoz-BhwdHi2mE8rfA4B8GXs7vuY1iufe3znhxVeJBOyG_Oj9gqMfTIZN0DCF2FzXxhzGP_GBO1oocUnXYwtnsV-Xf4dhj302Zkuw_5m30W_z04Xs5-T-a_zi9l0PrFcyGGi-FICq1oKUqklo5Iwy0lDWsekIUqpGhrhOHFMQM2MqeumpsxJbi2taWP5Ljp-5q7HZQ-tLdHJdHqdfG_SvY7G6_9fgl_pP_FWN4oypqoCONgAUrwZIQ-699lC15kAccyacSoFl6XVIv3-NutfyEvLRUCeBTbFnBM4bf3wVHmJ9p2mRD_OUr_OslgO31leqB-IHwBAN5_v
CitedBy_id crossref_primary_10_3389_fimmu_2022_946456
crossref_primary_10_1038_s41598_022_10631_z
crossref_primary_10_3390_jcm10040871
crossref_primary_10_3390_jcm9030877
crossref_primary_10_5937_mp72_32455
crossref_primary_10_3389_fimmu_2023_1123832
crossref_primary_10_3390_ijms252212327
Cites_doi 10.1016/j.humimm.2010.11.008
10.1038/sj.gene.6363752
10.1182/blood-2007-08-106385
10.1016/S0076-6879(06)19007-2
10.1111/sji.12409
10.1002/art.24181
10.1111/j.1600-065X.2009.00781.x
10.1101/gad.308619.117
10.1038/nm.3746
10.18632/oncotarget.23136
10.1146/annurev.immunol.24.021605.090535
10.1016/j.transci.2010.05.011
10.4103/0019-5049.144650
10.1097/00129804-200405000-00004
10.1371/journal.pone.0070824
10.1159/000489953
10.4103/2141-9248.157498
10.3109/08820139.2013.879594
10.18632/oncotarget.8714
10.1080/10245332.2018.1530179
10.1111/j.1423-0410.2011.01474.x
10.1016/j.cca.2009.03.037
10.2147/OTT.S173421
10.1161/01.CIR.97.6.562
10.1111/j.1365-2796.2007.01879.x
10.1007/s00432-018-2578-8
10.3109/10408369109106870
10.1056/NEJM199409083311001
10.1007/s12020-016-1096-1
10.1101/cshperspect.a034728
10.1016/j.cca.2017.09.010
10.1038/sj.bmt.1705850
ContentType Journal Article
Copyright 2019 by the authors. 2019
Copyright_xml – notice: 2019 by the authors. 2019
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.3390/jcm8111961
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
CrossRef
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2077-0383
ExternalDocumentID PMC6912294
31766247
10_3390_jcm8111961
Genre Journal Article
GrantInformation_xml – fundername: Chang Gung Memorial Hospital
  grantid: CMRPG3F0442 , CMRPG3I0261 and BMRPA81
GroupedDBID 53G
5VS
7X7
8FI
8FJ
AADQD
AAFWJ
AAYXX
ABDBF
ABUWG
ACUHS
ADBBV
AFKRA
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
CITATION
DIK
FYUFA
HMCUK
HYE
IAO
IHR
ITC
KQ8
M48
MODMG
M~E
OK1
PGMZT
PHGZM
PHGZT
PIMPY
RPM
UKHRP
GROUPED_DOAJ
NPM
7X8
5PM
ID FETCH-LOGICAL-c378t-93b8e24d1e899b21802c3060df28a09995e67f30f27e52aa556512f83cc1516c3
IEDL.DBID M48
ISSN 2077-0383
IngestDate Thu Aug 21 13:52:21 EDT 2025
Thu Jul 10 17:10:15 EDT 2025
Thu Jan 02 23:00:56 EST 2025
Tue Jul 01 04:33:54 EDT 2025
Thu Apr 24 23:03:48 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords CTLA4
gene polymorphism
leukoreduction
transfusion reaction
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c378t-93b8e24d1e899b21802c3060df28a09995e67f30f27e52aa556512f83cc1516c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/jcm8111961
PMID 31766247
PQID 2318738000
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6912294
proquest_miscellaneous_2318738000
pubmed_primary_31766247
crossref_citationtrail_10_3390_jcm8111961
crossref_primary_10_3390_jcm8111961
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20191113
PublicationDateYYYYMMDD 2019-11-13
PublicationDate_xml – month: 11
  year: 2019
  text: 20191113
  day: 13
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Journal of clinical medicine
PublicationTitleAlternate J Clin Med
PublicationYear 2019
Publisher MDPI
Publisher_xml – name: MDPI
References Chen (ref_13) 2017; 474
Frydecka (ref_29) 2017; 55
Mayr (ref_38) 2018; 11
Sahu (ref_3) 2014; 58
Ortolano (ref_7) 2004; 27
Encuentra (ref_21) 2007; 110
Azarian (ref_22) 2007; 11
Wu (ref_17) 2009; 403
Rajesh (ref_12) 2015; 5
Hawley (ref_14) 2006; 419
ref_31
Tsai (ref_1) 2010; 43
Brunet (ref_19) 2011; 18
Guo (ref_30) 2016; 26
Fang (ref_32) 2018; 47
Hammrich (ref_37) 2018; 144
Hermans (ref_11) 1998; 97
Yao (ref_35) 2019; 24
Mempel (ref_8) 1993; 31
Chang (ref_10) 2018; 9
Wang (ref_27) 2008; 263
Zou (ref_33) 2018; 11
Li (ref_15) 2009; 229
Sellami (ref_18) 2011; 72
ref_23
Mikhaylichenko (ref_25) 2018; 32
Tang (ref_34) 2016; 83
Schubert (ref_36) 2014; 20
Ligers (ref_28) 2001; 2
Heddle (ref_5) 1994; 331
Vannucchi (ref_20) 2007; 40
ref_2
Brown (ref_6) 2011; 101
Lichtiger (ref_9) 1991; 28
Karimi (ref_16) 2014; 43
Teft (ref_24) 2006; 24
Kolar (ref_26) 2009; 60
ref_4
References_xml – volume: 72
  start-page: 139
  year: 2011
  ident: ref_18
  article-title: Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant
  publication-title: Hum. Immunol.
  doi: 10.1016/j.humimm.2010.11.008
– volume: 2
  start-page: 145
  year: 2001
  ident: ref_28
  article-title: CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms
  publication-title: Genes Immun.
  doi: 10.1038/sj.gene.6363752
– volume: 11
  start-page: 4623
  year: 2007
  ident: ref_22
  article-title: Donor CTLA-4 +49 A/G*GG genotype is associated with chronic GVHD after HLA-identical haematopoietic stem-cell transplantations
  publication-title: Blood
  doi: 10.1182/blood-2007-08-106385
– volume: 419
  start-page: 149
  year: 2006
  ident: ref_14
  article-title: Hematopoietic Stem Cells
  publication-title: Methods Enzym.
  doi: 10.1016/S0076-6879(06)19007-2
– volume: 83
  start-page: 212
  year: 2016
  ident: ref_34
  article-title: Investigation of Cytotoxic T-lymphocyte antigen 4 Polymorphisms in Gastric Cardia Adenocarcinoma
  publication-title: Scand. J. Immunol.
  doi: 10.1111/sji.12409
– volume: 60
  start-page: 123
  year: 2009
  ident: ref_26
  article-title: CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.24181
– volume: 229
  start-page: 271
  year: 2009
  ident: ref_15
  article-title: Costimulatory pathways in transplantation: Challenges and new developments
  publication-title: Immunol. Rev.
  doi: 10.1111/j.1600-065X.2009.00781.x
– volume: 32
  start-page: 42
  year: 2018
  ident: ref_25
  article-title: The degree of enhancer or promoter activity is reflected by the levels and directionality of eRNA transcription
  publication-title: Genes Dev.
  doi: 10.1101/gad.308619.117
– volume: 20
  start-page: 1410
  year: 2014
  ident: ref_36
  article-title: Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations
  publication-title: Nat. Med.
  doi: 10.1038/nm.3746
– volume: 110
  start-page: 461
  year: 2007
  ident: ref_21
  article-title: CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA identical sibling donors
  publication-title: Blood J. Am. Soc. Hematol.
– volume: 9
  start-page: 4385
  year: 2018
  ident: ref_10
  article-title: Transfusion-associated adverse reactions (TAARs) and cytokine accumulations in the stored blood components: The impact of prestorage versus poststorage leukoreduction
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.23136
– volume: 24
  start-page: 65
  year: 2006
  ident: ref_24
  article-title: A molecular perspective of CTLA-4 function
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.24.021605.090535
– volume: 43
  start-page: 69
  year: 2010
  ident: ref_1
  article-title: Perfusion vs. oxygen delivery in transfusion with “fresh” and “old” red blood cells: The experimental evidence
  publication-title: Transfus. Apher. Sci.
  doi: 10.1016/j.transci.2010.05.011
– volume: 58
  start-page: 543
  year: 2014
  ident: ref_3
  article-title: Adverse events related to blood transfusion
  publication-title: Indian J. Anaesth.
  doi: 10.4103/0019-5049.144650
– volume: 27
  start-page: 157
  year: 2004
  ident: ref_7
  article-title: Contamination control in nursing with filtration: Part 2: Emerging rationale for bedside (final) filtration of prestorage leukocyte-reduced blood products
  publication-title: J. Infus. Nurs.
  doi: 10.1097/00129804-200405000-00004
– ident: ref_31
  doi: 10.1371/journal.pone.0070824
– volume: 47
  start-page: 414
  year: 2018
  ident: ref_32
  article-title: Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies
  publication-title: Cell. Physiol. Biochem.
  doi: 10.1159/000489953
– volume: 5
  start-page: 185
  year: 2015
  ident: ref_12
  article-title: Effects of Prestorage Leukoreduction on the Rate of Febrile Nonhemolytic Transfusion Reactions to Red Blood Cells in a Tertiary Care Hospital
  publication-title: Ann. Med. Health Sci. Res.
  doi: 10.4103/2141-9248.157498
– volume: 43
  start-page: 391
  year: 2014
  ident: ref_16
  article-title: Polymorphism of costimulatory molecules (CTLA4, ICOS, PD.1 and CD28) and allogeneic hematopoietic stem cell transplantation in Iranian patients
  publication-title: Immunol. Investig.
  doi: 10.3109/08820139.2013.879594
– volume: 26
  start-page: 23088
  year: 2016
  ident: ref_30
  article-title: Effect of CTLA-4 gene polymorphisms on long-term kidney allograft function in Han Chinese recipients
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.8714
– ident: ref_23
– volume: 24
  start-page: 123
  year: 2019
  ident: ref_35
  article-title: Association of cytotoxic T-lymphocyte antigen 4 gene with immune thrombocytopenia in Chinese Han children
  publication-title: Hematology
  doi: 10.1080/10245332.2018.1530179
– volume: 101
  start-page: 93
  year: 2011
  ident: ref_6
  article-title: Clinical relevance of the HLA system in blood transfusion
  publication-title: Vox Sang.
  doi: 10.1111/j.1423-0410.2011.01474.x
– volume: 403
  start-page: 229
  year: 2009
  ident: ref_17
  article-title: Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation
  publication-title: Clin. Chim. Acta
  doi: 10.1016/j.cca.2009.03.037
– ident: ref_4
– volume: 11
  start-page: 4609
  year: 2018
  ident: ref_33
  article-title: CTLA4 tagging polymorphisms and risk of colorectal cancer: A case–control study involving 2,306 subjects
  publication-title: Onco Targets Ther.
  doi: 10.2147/OTT.S173421
– volume: 97
  start-page: 562
  year: 1998
  ident: ref_11
  article-title: Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: A randomized clinical trial
  publication-title: Circulation
  doi: 10.1161/01.CIR.97.6.562
– ident: ref_2
– volume: 263
  start-page: 61
  year: 2008
  ident: ref_27
  article-title: Two SNPs in the promoter region of the CTLA-4 gene affect binding of transcription factors and are associated with human myasthenia gravis
  publication-title: J. Intern. Med.
  doi: 10.1111/j.1365-2796.2007.01879.x
– volume: 144
  start-page: 587
  year: 2018
  ident: ref_37
  article-title: CTLA-4 polymorphisms: Influence on transplant-related mortality and survival in children undergoing allogeneic hematopoietic stem cell transplantation
  publication-title: J. Cancer Res. Clin. Oncol.
  doi: 10.1007/s00432-018-2578-8
– volume: 28
  start-page: 387
  year: 1991
  ident: ref_9
  article-title: Leukocyte-poor blood components: Issues and indications
  publication-title: Crit. Rev. Clin. Lab. Sci.
  doi: 10.3109/10408369109106870
– volume: 331
  start-page: 625
  year: 1994
  ident: ref_5
  article-title: The role of the plasma from platelet concentrates in transfusion reactions
  publication-title: N. Eng. J. Med.
  doi: 10.1056/NEJM199409083311001
– volume: 55
  start-page: 186
  year: 2017
  ident: ref_29
  article-title: CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease
  publication-title: Endocrine
  doi: 10.1007/s12020-016-1096-1
– volume: 11
  start-page: a034728
  year: 2018
  ident: ref_38
  article-title: What Are 3′ UTRs Doing?
  publication-title: Cold Spring Harb. Perspect. Biol.
  doi: 10.1101/cshperspect.a034728
– volume: 18
  start-page: 100
  year: 2011
  ident: ref_19
  article-title: Donor CTLA-4 Genotype Influences Clinical Outcome after T Cell-Depleted Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donors
  publication-title: Biol. Blood Marrow Transplant.
– volume: 474
  start-page: 120
  year: 2017
  ident: ref_13
  article-title: Human platelet antigens are associated with febrile non-hemolytic transfusion reactions
  publication-title: Clin. Chim. Acta
  doi: 10.1016/j.cca.2017.09.010
– volume: 31
  start-page: 81
  year: 1993
  ident: ref_8
  article-title: Substitution of thrombocyte concentrates in polytransfused patients
  publication-title: Beitr. Infusionsther.
– volume: 40
  start-page: 1001
  year: 2007
  ident: ref_20
  article-title: Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation
  publication-title: Bone Marrow Transplant.
  doi: 10.1038/sj.bmt.1705850
SSID ssj0000884217
Score 2.145495
Snippet Leukocytes and cytokines in blood units have been known to be involved in febrile non-hemolytic transfusion reaction (FNHTR), and these adverse reactions still...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1961
Title Association of CTLA4 Gene Polymorphism with Transfusion Reaction after Infusion of Leukoreduced Blood Component
URI https://www.ncbi.nlm.nih.gov/pubmed/31766247
https://www.proquest.com/docview/2318738000
https://pubmed.ncbi.nlm.nih.gov/PMC6912294
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwEB5RkKpeKgp9bEtXruDCIa1jO7FzQBUgEK0AIcRKe4vWji1olwT2IcG_ZybJblng0GtiO9ZM7Pk-P74B2Ao68ZmwPOI2JEhQXIhsKELkUpVy4xBjh_qA7Gl61FO_-0l_CWb5O1sDjl-kdpRPqjcafr-7vf-JA36HGCdS9h9_3LXBIZsRC1rBiKQpk8FJC_PrGdkYJerku4JrHXFkZY1S6ZPqi7HpGeB8em7yUSA6XIW3LYJku43L38GSL9fg9Um7R74O1SOLsyqw_YvjXcVIXpqdVUOk-mjZq_E1oxVYVoeqMKUlM3bum0sOrM4bzn6V7XNs49hP_1YjUnn1Bdujs-6MJpKqxC6-h97hwcX-UdSmVYic1GYSZdIaL1QRe-RaVpAEnEPiwIsgzIAAY-JTHSQPQvtEDAYJYr5YBCOdQ3iQOvkBlkv8wCdg3FkXglXGFgF5Xma4DLFULrEqsc4VHdieGTR3reY4pb4Y5sg9yPj5P-N3YHNe9qZR2nix1LeZX3IcCLS7MSh9NR3nCFSNloh_eQc-Nn6atyNJBlMo3QG94MF5ARLZXnxTXl3WYttpFguRqc__1bsv8AYBVUZ3FWO5AcuT0dR_RdAysV14pfu6Cyt7B6dn5936_3wAk1_vHw
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+CTLA4+Gene+Polymorphism+with+Transfusion+Reaction+after+Infusion+of+Leukoreduced+Blood+Component&rft.jtitle=Journal+of+clinical+medicine&rft.au=Wen%2C+Ying-Hao&rft.au=Lin%2C+Wei-Tzu&rft.au=Wang%2C+Wei-Ting&rft.au=Chiueh%2C+Tzong-Shi&rft.date=2019-11-13&rft.issn=2077-0383&rft.eissn=2077-0383&rft.volume=8&rft.issue=11&rft.spage=1961&rft_id=info:doi/10.3390%2Fjcm8111961&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_jcm8111961
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2077-0383&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2077-0383&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2077-0383&client=summon